Xceed Biotechnology Limited - Strategic Analysis ReviewSummaryXceed Biotechnology Limited (Xceed) is principally engaged in the development of biodegradable polymers and a range of organo-boron chemicals. The company's operations are carried out through its two subsidiaries. It mainly develops NovoSorb, a product used in various applications such as orthopedics, orthodontics, drug delivery, wound care, cosmetic surgery, tissue engineering, nerve regeneration, and cartilage repair. It is headquartered in Clayton, Australia and employs 30 people. Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of Xceed Biotechnology Limited. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.Scope' The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. ' The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. ' The report contains critical company information ' business structure and operations, company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.Reasons to buy' A quick 'one-stop-shop' to understand the company. ' Enhance business/sales activities by understanding customers' businesses better.' Get detailed information and financial & strategic analysis on companies operating in your industry.' Identify prospective partners and suppliers ' with key data on their businesses and locations.' Capitalize on competitors' weaknesses and target the market opportunities available to them.' Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Xceed Biotechnology Limited - Strategic Analysis Review
Published on February 2009
Report Summary
Xceed Biotechnology Limited - Strategic Analysis Review
Summary
Xceed Biotechnology Limited (Xceed) is principally engaged in the development of biodegradable polymers and a range of
organo-boron chemicals. The company's operations are carried out through its two subsidiaries. It mainly develops NovoSorb, a
product used in various applications such as orthopedics, orthodontics, drug delivery, wound care, cosmetic surgery, tissue
engineering, nerve regeneration, and cartilage repair. It is headquartered in Clayton, Australia and employs 30 people.
Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of Xceed
Biotechnology Limited. The report provides a comprehensive insight into the company, including business structure and operations,
executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's
views on the company.
Scope
' The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational
factors are considered.
' The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
' The report contains critical company information ' business structure and operations, company history, major products and services,
key competitors, key employees and executive biographies, different locations and important subsidiaries.
Reasons to buy
' A quick 'one-stop-shop' to understand the company.
' Enhance business/sales activities by understanding customers' businesses better.
' Get detailed information and financial & strategic analysis on companies operating in your industry.
' Identify prospective partners and suppliers ' with key data on their businesses and locations.
' Capitalize on competitors' weaknesses and target the market opportunities available to them.
' Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Table of Content
Table Of Contents
Xceed Biotechnology Limited - Strategic Analysis Review Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Key Information 1
Key Facts 1
Table Of Contents 2
List of Tables 2
Business Description 3
Major Products and Services 4
Overview 4
SWOT Analysis Overview 5
Overview 5
Xceed Biotechnology Limited - Strengths 5
Increasing Revenues 5
Proprietary Technologies 5
Xceed Biotechnology Limited - Weaknesses 5
Operating Losses 5
Xceed Biotechnology Limited - Opportunities 5
Contracts and Agreements 5
Additional Funding Raised 5
Market Growth 5
Xceed Biotechnology Limited - Threats 5
Competition 5
Technological Changes 5
Key Employees 6
Key Employee Biographies 6
Company Statement 7
Locations And Subsidiaries 9
Head Office 9
Other Locations & Subsidiaries 9
Appendix 10
Methodology 10
About Global Markets Direct 10
Contact Us 10
Disclaimer 10
List of Tables
Xceed Biotechnology Limited, Key Facts, 2005 1
Xceed Biotechnology Limited, Key Facts 1
Major Products and Services 4
Xceed Biotechnology Limited, Key Employee Biographies 6
Xceed Biotechnology Limited - Strategic Analysis Review Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Xceed Biotechnology Limited - Strategic Analysis Review
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Xceed Biotechnology Limited - Strategic Analysis Review Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Xceed Biotechnology Limited - Strategic Analysis Review Page 4/4